Scholarlink

<p>Epidermal growth factor receptor antibodies and tyrosine kinase inhibitors cause various skin toxicities. Acneiform rash, paronychia, and pruritus are the major side effects, and their incidence is high, especially in Asian patients. These skin disorders greatly reduce the patients’ quality of life and can affect treatment intensity. As the incidence and severity of these skin toxicities correlate with treatment effects, adequate management during the treatment period is essential. Guidelines and treatment recommendations exist for epidermal growth factor receptor inhibitor-related skin toxicities. However, there have been no previous reviews of studies on Asian patients. In this review, we discuss the possible preventive and therapeutic recommendations for Asian patients. We derived recommendations based on evidence from Asian patients. This review will contribute to the management of these toxicities in Asian populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Epidermal growth factor receptor inhibitor-related skin toxicities: a review of management and possible preventive and therapeutic approaches for Asian patients by the Japanese Pharmacist-led Oncodermatology Study Team

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月1日

查看全文
  • Yohei Iimura,
  • Hirotoshi Iihara,
  • Yoshitaka Saito,
  • Hisanaga Nomura,
  • Takuya Iwamoto,
  • Mayumi Kotera,
  • Yusuke Tsuchiya,
  • Tatsuya Sumiya,
  • Mariko Kono,
  • Daisuke Hirate,
  • Tomohiro Kurokawa,
  • Toshinobu Hayashi,
  • Hironobu Hashimoto,
  • Junichi Higuchi,
  • Ryuta Urakawa,
  • Hiroyuki Saotome,
  • Seiichiro Kuroda

摘要

Epidermal growth factor receptor antibodies and tyrosine kinase inhibitors cause various skin toxicities. Acneiform rash, paronychia, and pruritus are the major side effects, and their incidence is high, especially in Asian patients. These skin disorders greatly reduce the patients’ quality of life and can affect treatment intensity. As the incidence and severity of these skin toxicities correlate with treatment effects, adequate management during the treatment period is essential. Guidelines and treatment recommendations exist for epidermal growth factor receptor inhibitor-related skin toxicities. However, there have been no previous reviews of studies on Asian patients. In this review, we discuss the possible preventive and therapeutic recommendations for Asian patients. We derived recommendations based on evidence from Asian patients. This review will contribute to the management of these toxicities in Asian populations.